Ocular melanoma is not associated with CDKN2A or MC1R variants - A population-based study

Melanoma Research

Volumn 13, Issue 4, 2003, Pages 409-413

  Vajdic, C ^a,b   Kricker, A ^c   Duffy, D L ^d   Aitken, J F ^e   Stark, M ^d   Ter Huurne, J A C ^f   Martin, N G ^d   Armstrong, B K ^b,g   Hayward, N K ^c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NSW   (Australia)

^c National Breast Cancer Centre   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e Epidemiology Services Unit   (Australia)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CDKN2A; MC1R; Ocular melanoma; Polymorphisms

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DNA; MELANOCORTIN RECEPTOR; PROTEIN P16;

ADULT; ARTICLE; CANCER RISK; CDKN2A GENE; CHOROID TUMOR; CILIARY BODY TUMOR; CONJUNCTIVA TUMOR; CONTROLLED STUDY; DNA SEQUENCE; EYE TUMOR; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; IRIS TUMOR; MAJOR CLINICAL STUDY; MC1R GENE; MELANOCORTIN 1 RECEPTOR GENE; MELANOMA; POLYMERASE CHAIN REACTION; POPULATION RISK; PRIORITY JOURNAL; RECEPTOR GENE; TUMOR VOLUME;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA, NEOPLASM; EYE NEOPLASMS; GENES, P16; GENETICS, POPULATION; GERM-LINE MUTATION; HUMANS; MELANOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTOR, MELANOCORTIN, TYPE 1;

EID: 0042367507     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200308000-00011     Document Type: Article

References (28)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol. VII. International Agency for Research on Cancer (IARC) Scientific Publication 143. Lyon: IARC; 1997.
2. Singh AD, Wang MX, Donoso LA, Shields CL, De Potter P, Shields JA. Genetic aspects of uveal melanoma: a brief review. Semin Oncol 1996; 23:768-772.
3. Van Hees CL, Jager MJ, Bleeker JC, Kemme H, Bergman W. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res 1998; 8:175-180.
4. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q 12-13. Am J Hum Genet 1997; 61:120-128.
5. Sinilnikova OM, Egan KM, Quinn JL, Boutrand L, Lenoir GM, Stoppa-Lyonnet D, et al. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer 1999; 82:325-328.
6. Iscovich J, Abdulrosik M, Cour C, Fischbein A, Pe'er J, Goldgar D. Prevalence of the BRCA2 6174delT mutation in Israeli uveal melanoma patients. Int J Cancer 2002; 98:42-44.
7. Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 1999; 91:446-452.
8. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 1994; 54:5269-5272.
9. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66:176-186.
10. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117:294-300.
11. Wang X, Egan KM, Gragoudas ES, Kelsey KT. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res 1996; 6:405-410.
12. Singh AD, Croce CM, Wary KK, Shields JA, Donoso LA, Shields CL, et al. Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16). Ophthalmic Genet 1996; 17:39-40.
13. Blasi MA, Binni F, De Bernardo C, Grammatico B, Balestrazzi E, Grammatico P. Analysis of CDKN2A constitutional mutations in 15 patients affected by uveal melanoma. Invest Ophthalmol Vis Sci 2000;41:S382.
14. ARF or cdk4 genes. Br J Cancer 2000; 82:818-822.
15. Metzelaar-Blok JA, ter Huurne JA, Hurks HM, Keunen JE, Jager MJ, Gruis NA. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients. Invest Ophthalmol Vis Sci 2001; 42:1951-1954.
16. Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, et al. Eye color and cutaneous nevi predict risk of ocular melanoma in Australia. Int J Cancer 2001; 92:906-912.
17. Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002; 101:175-182.
18. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone variant alleles in twins with red hair. Hum Mol Genet 1997; 6:367-376.
19. Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, et al. CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res 1997; 57:4868-4875.
20. Pollock PM, Stark MS, Palmer JM, Walters MK, Aitken JF, Martin NG, et al. Mutation analysis of the CDKN2A promoter in Australian melanoma families. Genes Chromosom Cancer 2001; 32:89-94.
21. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Computational Graph Stat 1996; 5:299-314.
22. Merbs SL, Sidransky D. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma. Invest Ophthalmol Vis Sci 1999; 40:779-783.
23. van der Velden PA, Metzelaar-Blok JA, Bergman W, Monique H, Hurks H, Frants RR, et al. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma. Cancer Res 2001; 61:5303-5306.
24. Sarna T. Properties and function of the ocular melanin-a photobiophysical view. J Photochem Photobiol 1992; 12:215-258.
25. Sahm M, Loeffler KU, Seifert P, Spitznas M. Effect of ultraviolet radiation on melanogenesis in four different types of cultured bovine ocular pigmented cells. Graefe's Arch Clin Exp Ophthalmol 2001; 239:302-309.
26. Hu DN, McCormick SA, Orlow SJ, Rosenblat S, Lin AY. Regulation of melanogenesis by human uveal melanocytes in vitro. Exp Eye Res 1997; 64:397-404.
27. Boissy RE. The melanocyte. Its structure, function, and subpopulations in skin, eyes, and hair. Dermatol Clin 1988; 6:161-173.
28. Smith-Thomas LC, Moustafa M, Dawson RA, Wagner M, Balafa C, Haycock JW, et al. Cellular and hormonal regulation of pigmentation in human ocular melanocytes. Pigment Cell Res 2001; 14:298-309.